Nasonex and Genotropin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nasonex (mometasone furoate monohydrate) and Genotropin (somatropin recombinant). Common drug interactions include pain among females and injection site pain among males.

The phase IV clinical study analyzes what interactions people have when they take Nasonex and Genotropin. It is created by eHealthMe based on reports of 48 people who take the same drugs from the FDA, and is updated regularly.

What is Nasonex?

Nasonex has active ingredients of mometasone furoate monohydrate. It is often used in allergies. eHealthMe is studying from 32,299 Nasonex users. Check the latest studies of Nasonex.

What is Genotropin?

Genotropin has active ingredients of somatropin recombinant. It is often used in growth hormone deficiency. eHealthMe is studying from 41,924 Genotropin users. Check the latest studies of Genotropin.



On Jul, 08, 2026

48 people who take Nasonex and Genotropin together, and have interactions are studied.

Nasonex and Genotropin drug interactions.

What are the common drug interactions of Nasonex and Genotropin, by gender? *:

female:

  1. Pain
  2. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  3. Rash
  4. Sepsis (a severe blood infection that can lead to organ failure and death)
  5. Sleep disorder due to general medical condition, insomnia type (a conditions that prevent a person from getting restful sleep due to mental condition of not getting sleep)
  6. Thrombocytopenia (decrease of platelets in blood)
  7. Urinary tract infection
  8. White blood cell count decreased
  9. Nausea (feeling of having an urge to vomit)
  10. Chills (felling of cold)

male:

  1. Injection site pain
  2. Injection site haematoma (localized swelling filled with blood at injection site)
  3. Malaise (a feeling of general discomfort or uneasiness)
  4. Pain in extremity
  5. Apathy
  6. Asthma
  7. Blood cholesterol increased
  8. Bone density decreased
  9. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  10. Dizziness

What are the common drug interactions of Nasonex and Genotropin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Injection site pain
  2. Injection site erythema (redness at injection site)
  3. Injection site urticaria (rash of round, red welts on the skin at injection site)
  4. Injection site bruising
  5. Injection site haematoma (localized swelling filled with blood at injection site)
  6. Influenza
  7. Injection site reaction
  8. Drug ineffective
  9. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  10. Abdominal pain

10-19:

  1. Headache (pain in head)
  2. Pain in extremity
  3. Scoliosis (a medical condition in which a person's spine is curved from side to side)
  4. Injection site pain
  5. Asthma
  6. Blood cholesterol increased
  7. Bone density decreased
  8. Dizziness
  9. Migraine (headache)
  10. Nausea (feeling of having an urge to vomit)

20-29:

  1. Dermatillomania (skin picking disorders)
  2. Weight increased

30-39:

n/a

40-49:

  1. Abdominal pain
  2. Acne (skin problems that cause pimples)
  3. Arthralgia (joint pain)
  4. Diarrhoea
  5. Influenza
  6. Nausea (feeling of having an urge to vomit)
  7. Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
  8. Restless legs syndrome (a powerful urge to move your legs)
  9. Sleep disorder
  10. Thirst

50-59:

  1. Eye disorder
  2. Fall
  3. Fatigue (feeling of tiredness)
  4. Fibromyalgia (a long-term condition which causes pain all over the body)
  5. Influenza
  6. Injection site haematoma (localized swelling filled with blood at injection site)
  7. Insomnia (sleeplessness)
  8. Joint injury
  9. Malaise (a feeling of general discomfort or uneasiness)
  10. Osteopenia (a condition where bone mineral density is lower than normal)

60+:

  1. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  2. Oesophageal spasm (contraction of oesophagus)

What are the existing conditions these people have? *

  1. Asthma: 14 people, 29.17%
  2. Hypopituitarism (diminished hormone secretion by the pituitary gland, causing dwarfism in children and premature aging in adults): 8 people, 16.67%
  3. High Blood Pressure: 6 people, 12.50%
  4. Body Height Below Normal: 6 people, 12.50%
  5. Hypersensitivity: 5 people, 10.42%
  6. Pulmonary Embolism (blockage of the main artery of the lung): 4 people, 8.33%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 8.33%
  8. Failure To Thrive (inadequate weight gain and physical growth in children): 4 people, 8.33%
  9. Depression: 4 people, 8.33%
  10. Small For Dates Baby (an unborn baby is growing more slowly and is smaller than most babies are at the same age): 3 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Nasonex and Genotropin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Nasonex and Genotropin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Nasonex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Genotropin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nasonex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Genotropin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on mometasone furoate monohydrate and somatropin recombinant (the active ingredients of Nasonex and Genotropin, respectively), and Nasonex and Genotropin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: